✨ Looking ahead to 2026 ✨
As we step into a new year, we invite you to discover our CEO’s message Olivier Rousseau, reflecting on a 2025 marked by challenges, progress and strong collective achievements at SGD Pharma.
🌱 Sustainability: we've set ambitious targets. 42% reduction of CO2 emissions between 2022 and 2030, validated by SBTi. We’re proud to have earned Platinum status from EcoVadis in 2025, a recognition that places us among the 1% top-performing glass manufacturers worldwide in terms of ESG practices. In 2026, we will build our first hybrid furnace.
🏭 Operational excellence: strong performances across several Business Units and industrial sites, supported by a record level of CAPEX to modernize our furnaces and production lines.
🚀 Growth & innovation: the launch of new solutions, the acceleration of our global tubular business, and the acquisition of Alphial, strengthening our leadership in ampoules and RTU vials.
A heartfelt thank you to all our teams worldwide for their commitment and dedication throughout the year.
Our strategy is moving forward, our teams are fully engaged, and 2026 is shaping up to be another important milestone for SGD Pharma.
All of us at SGD Pharma wish you and your loved ones a very happy, healthy and safe 2026 💙
SGDPharma HappyNewYear2026 Innovation Sustainability OperationalExcellence TeamSpirit